3/10/2017 1 Disclosure None Lymphatic Anatomy and Flow Lung Lymphatic System
(Riquet M, Thorac Surg Clin 17 (2007) 619–638)
Disclosure None Lymphatic Anatomy and Flow Lung Lymphatic System - - PowerPoint PPT Presentation
3/10/2017 Disclosure None Lymphatic Anatomy and Flow Lung Lymphatic System (Riquet M, Thorac Surg Clin 17 (2007) 619638) 1 3/10/2017 Lymphatic Imaging Lymph flow disorders LAG T2W MRI DCMRL Lymphatic Lymphatic Conduction
(Riquet M, Thorac Surg Clin 17 (2007) 619–638)
LAG
(Dori et al. AJR 2014, Radiology 2014, Pediatrics 2014)
T2W MRI DCMRL
Lymphatic leaks
Lymph flow disorders
Conduction abnormalities Lymphedema Lymphatic
Traumatic Idiopathic Perfusion abnormalities Mesentery Liver Ascites PLE Lung Paravertebral Chyloptysis Chylothorax PB Pulm edema Lung disease NC, CLFD Kidney Chylurea Heart Chylopericardium Tissue Edema Anasarca
♥ Lung function shortly after birth is dependent on: 1) Lung surfactant lung compliance 2) Lymphatic function to adsorb fluid Surfactant deficiency RDS Lymph dysfunction lung edema lung compliance RDS ♥ CCBE1 = lymphangiogenic factor ♥ CCBE1 -/- mice lack a lymphatic system but have otherwise normal lung anatomy ♥ Prenatal: Normal CV system Tissue edema ♥ Post natal: Death from RDS Unable to inflate the lungs
(Jakus et al. JEM 2014)
(Saul et al. Ped. Rad. 2016)
Patterns of central lymphatic flow in CLFD: ♥ Abnormal conduction PLPS ♥ TD outlet obstruction PLPS, Dermal flow ♥ Functional TD outlet obstruction PLPS, Dermal flow ♥ Secondary obstruction PLPS, Dermal flow
Before After 24 hours
Glenn with chylothorax Fontan with chylothorax Fontan with PB
(Dori et al. Circulation 2016)
(Dori et al. Pediatrics 2014)
♥ 6 yo HLHS s/p Fontan with severe PB
PIP
1 2 3 4 5 6 7 8 9 7/31/14 8/1/14 8/2/14 8/3/14 8/4/14 8/5/14 8/6/14 8/7/14 8/8/14 8/9/14PEEP
Procedure Date Procedure Date
5 10 15 20 25 7/31/14 8/1/14 8/2/14 8/3/14 8/4/14 8/5/14 8/6/14 8/7/14 8/8/14 8/9/14
PS
20 40 60 80 100 120 7/31/14 8/2/14 8/4/14 8/6/14 8/8/14 8/10/14 8/12/14 8/14/14 8/16/14 8/18/14 8/20/14 8/22/14 8/24/14 8/26/14 8/28/14 8/30/14
FiO2
Procedure Date Procedure Date
♥ Discharged home 2 weeks post procedure ♥ No complications
70 72 74 76 78 80 82 84 86 88 90 7 / 3 1 / 1 4 8 / 2 / 1 4 8 / 4 / 1 4 8 / 6 / 1 4 8 / 8 / 1 4 8 / 1 / 1 4 8 / 1 2 / 1 4 8 / 1 4 / 1 4 8 / 1 6 / 1 4 8 / 1 8 / 1 4 8 / 2 / 1 4 8 / 2 2 / 1 4 8 / 2 4 / 1 4 8 / 2 6 / 1 4 8 / 2 8 / 1 4 8 / 3 / 1 4Sat
Procedure Date
(Itkin et al. Ann. ATS 2016)
♥ 76 yo with severe idiopathic PB
♥ 57 yo with chyloptysis
n 5 year overall survival ± SE (%) GSD patients complicated by effusion 20 94 ± 6 GLA patients complicated by effusion 77 84 ± 5 GSD/GLA patients without effusion 55 100 (N/A)
ww.lymphaticregistry.org
Slide courtesy of Dr. Cameron Trenor
♥ 11 yo with GLA and chylothorax
♥ 4 yo with KLA and persistent chylothorax
♥ Lymphatic flow disorders are serious, sometimes life threatening diseases ♥ PLPS can lead to abnormal lung mechanics and disease ♥ Imaging is the key first step in diagnosis and to guide therapy ♥ New lymphatic treatments are now available